Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion Biopsy

Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1

Kasivisvanathan, 2018, MRI-targeted or standard biopsy for prostate-cancer diagnosis, N Engl J Med, 318, 1767, 10.1056/NEJMoa1801993

Rouvière, 2019, Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study, Lancet Oncol, 20, 100, 10.1016/S1470-2045(18)30569-2

van der Leest, 2019, Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective mu, Eur Urol, 75, 570, 10.1016/j.eururo.2018.11.023

Drost, 2019, Prostate MRI, with or without targeted biopsy and standard biopsy for detecting prostate cancer: A Cochrane systematic review and meta-analysis, Cochrane Database Syst Rev, 4

Mottet, 2019

Padhani, 2019, Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 status update and future directions, Eur Urol, 75, 385, 10.1016/j.eururo.2018.05.035

Ahdoot, 2020, MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis, N Engl J Med, 382, 917, 10.1056/NEJMoa1910038

Panebianco, 2018, Negative multiparametric magnetic resonance imaging for prostate cancer: what’s next?, Eur Urol, 74, 48, 10.1016/j.eururo.2018.03.007

Bryk, 2017, The role of ipsilateral and contralateral transrectal ultrasound-guided systematic prostate biopsy in men with unilateral magnetic resonance imaging lesion undergoing magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy, Urology, 102, 178, 10.1016/j.urology.2016.11.017

Baco, 2015, Magnetic resonance imaging-transrectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients, Eur Urol, 67, 787, 10.1016/j.eururo.2014.08.077

Radtke, 2016, Multiparametric magnetic resonance imaging (MRI) and MRI – transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen, Eur Urol, 70, 846, 10.1016/j.eururo.2015.12.052

Hansen, 2017, Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy, BJU Int, 120, 631, 10.1111/bju.13711

Calio, 2018, Risk of upgrading from prostate biopsy to radical prostatectomy pathology—does saturation biopsy of index lesion during multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsy help?, J Urol, 199, 976, 10.1016/j.juro.2017.10.048

Kuru, 2013, Definitions of terms, processes and a minimum dataset for transperineal Prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics, BJU Int, 112, 568, 10.1111/bju.12132

Püllen, 2020, External validation of novel magnetic resonance imaging-based models for prostate cancer prediction, BJU Int, 125, 407, 10.1111/bju.14958

Weinreb, 2016, PI-RADS Prostate Imaging and Reporting and Data System: 2015, version 2, Eur Urol, 69, 16, 10.1016/j.eururo.2015.08.052

Kesch, 2017, TOP: Prospective evaluation of a volume based, computer assisted method for transperineal optimized prostate biopsy, Urol Int, 99, 149, 10.1159/000458764

Epstein, 2016, The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system, Am J Surg Pathol, 40, 244, 10.1097/PAS.0000000000000530

Moore, 2013, Standards of Reporting for MRI-targeted Biopsy Studies (START) of the prostate: recommendations from an international working group, Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030

Tango, 1998, Equivalence test and confidence interval for the difference in proportions for the paired-sample design, Stat Med, 17, 891, 10.1002/(SICI)1097-0258(19980430)17:8<891::AID-SIM780>3.0.CO;2-B

Bossuyt, 2003, Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative, Radiology, 226, 24, 10.1148/radiol.2261021292

Turkbey, 2019, Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2, Eur Urol, 76, 340, 10.1016/j.eururo.2019.02.033

Hansen, 2020, Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy, BJU Int, 125, 260, 10.1111/bju.14865

Mischinger, 2018, Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy, BJU Int, 121, 791, 10.1111/bju.14089

Calio, 2017, Changes in prostate cancer detection rate of MRI-TRUS fusion vs systematic biopsy over time: evidence of a learning curve, Prostate Cancer Prostatic Dis, 20, 436, 10.1038/pcan.2017.34

Le Nobin, 2015, Image guided focal therapy of MRI-visible prostate cancer: defining a 3D treatment margin based on MRI-histology co-registration analysis, J Urol, 194, 364, 10.1016/j.juro.2015.02.080

Bonekamp, 2018, Histopathological to multiparametric MRI spatial mapping of extended systematic sextant and MR/TRUS-fusion-targeted biopsy of the prostate Standards of Reporting of Diagnostic Accuracy, Eur Radiol, 29, 1820, 10.1007/s00330-018-5751-1

Ullrich, 2018, Risk stratification of ‘equivocal’ PI-RADS lesions in mp-MRI of the prostate, J Urol, 199, 691, 10.1016/j.juro.2017.09.074

Rosenkrantz, 2016, Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists, Radiology, 280, 793, 10.1148/radiol.2016152542

Faria, 2018, Optimising the diagnosis of Prostate cancer in the era of multiparametric magnetic resonance Imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS), Eur Urol, 73, 23, 10.1016/j.eururo.2017.08.018